HNL Lab's Digital Pathology Platform Enables Faster Results and More

Why It Matters

Digital pathology accelerates diagnoses, mitigates pathologist shortages, and enhances staff morale, giving health systems a strategic edge in patient care and talent recruitment.

Key Takeaways

• Digital pathology cut slide transport time from days to minutes
• Remote work increased pathologist morale; 81% prefer digital
• Turnaround time for molecular cases improved by one day
• Six Leica GT450 scanners and Proscia platform deployed network‑wide
• AI algorithm validation underway to boost prostate pathology efficiency

Pulse Analysis

The shift toward digital pathology has accelerated across large health systems as hospitals seek to streamline diagnostics and address a nationwide shortage of pathologists. By converting glass slides into high‑resolution images, institutions can eliminate physical transport, enable instant case sharing, and lay the groundwork for remote interpretation. This trend aligns with broader telehealth adoption and the push for data‑driven care, where speed and accuracy directly affect treatment outcomes. HNL Lab Medicine’s decision reflects these market forces, positioning the network to compete for talent and improve patient experience.

HNL Lab Medicine equipped its anatomic pathology suite with six Leica GT450 whole‑slide scanners and Proscia’s Concentriq digital platform. Within a year, all 25 pathologists transitioned to the system, gaining real‑time access to cases across 14 hospitals spanning 50 miles. The digital workflow cut slide‑transport time from days to minutes, enabled pathologists to work from home two to three days per week, and shaved at least one business day from molecular test turnaround. An internal poll showed 81 % of staff now prefer the digital interface, boosting morale and recruitment.

The next phase focuses on artificial‑intelligence augmentation, with HNL Lab entering validation for the Ibex Prostate algorithm. AI‑driven analysis promises faster, more consistent interpretations and a built‑in quality‑assurance layer, addressing both efficiency and diagnostic confidence. As more health systems adopt similar platforms, vendors that combine reliable scanning hardware with scalable software and AI pipelines will capture market share. For providers, the ability to outsource overflow work and maintain a flexible, remote‑ready workforce could become a decisive competitive advantage in an increasingly digital pathology landscape.